Leflunomide: a treatment option for ganciclovir-resistant cytomegalovirus infection after renal transplantation

Cytomegalovirus (CMV) infection after renal transplantation is a problem of increasing concern resulting in significant morbidity and mortality. Widespread use of ganciclovir (GCV) and valganciclovir (VGCV) may cause an increase of CMV resistance to these first line drugs. Other treatment options ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrassy, Joachim, Illner, Wilf Dieter, Rentsch, Markus, Jaeger, Gundula, Jauch, Karl W., Fischereder, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421354/
https://www.ncbi.nlm.nih.gov/pubmed/25949314
http://dx.doi.org/10.1093/ndtplus/sfp004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421354/
https://www.ncbi.nlm.nih.gov/pubmed/25949314
http://dx.doi.org/10.1093/ndtplus/sfp004

Ejemplares similares